This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
In the last few years, Astellas has invested heavily in novel technologies that ...
WEDNESDAY, Feb. 12, 2025 -- Use of secondary cardiovascular disease (CVD) preven...
WEDNESDAY, Feb. 12, 2025 -- For patients undergoing prostate radiotherapy, acute...
WEDNESDAY, Feb. 12, 2025 -- For the Preeclampsia Integrated Estimate of RiSk (PI...
WEDNESDAY, Feb. 12, 2025 -- Overdiagnosis of thyroid cancer in the United States...
WEDNESDAY, Feb. 12, 2025 -- Lithium is associated with an increased risk for thy...
WEDNESDAY, Feb. 12, 2025 -- Individuals who require hospital-based care for cann...
WEDNESDAY, Feb. 12, 2025 -- Post-COVID condition (PCC) continues to affect chil...
WEDNESDAY, Feb. 12, 2025 -- For infants born before 34 weeks of gestation and wi...
The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 mil...
Orchard Therapeutics has tasked Robin Kenselaar with accelerating growth of Lenm...
To guide children through an atypical hemolytic uremic syndrome diagnosis and su...
A small semaglutide trial suggests the medicine's suppression of appetite may ex...
Abbott had claimed that Sinocare’s iCan i3 wearable CGM was too similar to its F...
The web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guid...
While the continued erosion of Biogen’s multiple sclerosis franchise and weaker-...
After calling Rockville, Maryland, home for more than eight years, GSK's vaccine...
The agreement hands Biogen as much as $250 million in exchange for milestone pay...
Human medicines European public assessment report (EPAR): Skytrofa (previously L...
AnaptysBio may have ended last year on a low, but 2025 is looking up with the ne...
In this tracker, Fierce Pharma is recording the regulatory progress of in-market...
Human medicines European public assessment report (EPAR): Actelsar HCT, telmisar...
While Trump’s executive order provides substantial power to Elon Musk’s DOGE eff...
Human medicines European public assessment report (EPAR): Copalia HCT, amlodipin...